Faeth Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.1M | $-8.0M | $-7.4M | $-7.1M | $-9.4M | $-10.2M | $-12.2M | $-13.4M |
| Depreciation & Amortization | $135.0K | $137.0K | $135.0K | $137.0K | $138.0K | $161.0K | $162.0K | $151.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $795.0K | $1.2M | $1.1M | $1.0M | $1.1M | $1.2M | $1.4M | $1.5M |
| Net Cash from Operating Activities | $-5.8M | $-7.6M | $-6.2M | $-4.7M | $-9.5M | $-11.7M | $-9.6M | $-6.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $109.0K | $37.0K | $0 | $0 | $29.0K | $151.0K | $0 | $250.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $6.9M | $5.8M | $8.3M | $8.3M | $19.5M | $2.3M | $16.0M | $8.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-180.0K | $-209.0K | $-431.0K | $-2.5M | $-7.9M | $-262.0K | — | — |
| Net Change in Cash | $935.0K | $-2.1M | $1.7M | $1.1M | $2.1M | $-9.7M | $6.3M | $1.6M |
| Free Cash Flow | $-5.9M | $-7.7M | $-6.2M | $-4.7M | $-9.5M | $-11.9M | $-9.6M | $-7.1M |